View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Pembrolizumab 200, Non-Small Cell Lung Cancer, Second Line
Protocol-ID: 808 V2.0 (Mini), PEMB200, NSCLC, second lineIndication(s)
- Lung Carcinoma, Non-Small Cell (PD-L1 from 1%); ICD-10 C34.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 21.09.2018